Continuous Bioprocessing Market To witness Huge Expansion By 2030
Continuous Bioprocessing Market Summary The global continuous bioprocessing market size was estimated at USD 349.3 million in 2024 and is projected to reach USD 911.4 million by 2030, growing at a significant compound annual growth rate (CAGR) of 18.63% from 2025 to 2030. This impressive growth is primarily driven by the increasing demand for cost-efficient, scalable, and flexible biopharmaceutical production solutions, especially for the manufacturing of monoclonal antibodies (mAbs), vaccines, and advanced cell and gene therapies. Continuous bioprocessing offers distinct advantages over traditional batch processing methods by supporting process intensification—achieved through automation, real-time process analytics, and the use of single-use technologies. These advancements significantly enhance overall productivity, reduce production times, and minimize operational costs. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicin...